United States
Dr. Ben Bikman is a professor of Cell Biology and Physiology at Brigham Young University in Utah, where his laboratory research centers on insulin resistance as a foundational driver of obesity, type 2 diabetes, and chronic metabolic disease.
Total Followers +2.2%
229K
Across YouTube
Primary Platform
YouTube
229K followers · 100% of audience
Engagement
5.1%
vs. 1.5% category median
Sponsorship Tier
Mid
Bikman joined Metabolic Mind to outline a new approach to GLP-1 medications — using microdoses to curb carbohydrate cravings as a bridge to long-term metabolic health rather than a permanent fix.
In a wide-ranging conversation, Bikman discussed how insulin resistance underlies obesity, type 2 diabetes, and dementia, and how food, fasting, and lifestyle changes can reverse the condition.
Bikman joined FoundMyFitness for an extensive episode covering dietary drivers of metabolic dysfunction, evidence-based tactics for improving insulin sensitivity, and a critical look at GLP-1 medications like Ozempic.
Bikman appeared on one of YouTube's most-watched interview shows to discuss the dangers of elevated insulin, metabolic disease prevalence, and the links between sugar, Alzheimer's, and cancer risk.
Filmed in late January 2025, the episode covered motivating health behavior without government intervention, the role of protein and fat in the human diet, and the sugar addiction crisis.
| Platform | Followers | 30d Growth | Engagement | Posts / wk | Last upload |
|---|---|---|---|---|---|
| YouTube | 229,000 | +5K | 5.1% | 0.7 | 16 days ago |
| Window | YouTube | Combined | ||
|---|---|---|---|---|
| Last 7 days | +0 +0.0% | +0 +0.0% | +0 +0.0% | +0 |
| Last 30 days | +5K +2.2% | +0 +0.0% | +0 +0.0% | +5K |
| Last 90 days | +22K +9.6% | +0 +0.0% | +0 +0.0% | +22K |
| Last 365 days | +22K +9.6% | +0 +0.0% | +0 +0.0% | +22K |
Daily follower snapshots from CreatorDB's longitudinal index.
| Brand | Type | Platform | Date | Performance vs. baseline |
|---|---|---|---|---|
| Ketone-IQ Sponsorship | Sponsored content | YouTube | Jun 2025 | — |
| HLTH Code Nutrition / Metabolic Health | Co-founder | YouTube | 2021–Long-term | — |
Dr. Ben Bikman is a professor of Cell Biology and Physiology at Brigham Young University in Utah, where his laboratory research centers on insulin resistance as a foundational driver of obesity, type 2 diabetes, and chronic metabolic disease. He holds a doctorate in bioenergetics and translated years of academic work into a widely read book, "Why We Get Sick," which argues that hyperinsulinemia underpins most modern chronic illness. His YouTube channel extends that thesis into short, direct educational clips — covering hormonal signaling, fat versus glucose metabolism, and dietary strategy — delivered with academic precision rather than influencer sensationalism.
His audience skews toward adults aged 45 and older, with a meaningful cohort in the 25–34 range, suggesting he attracts both middle-aged individuals actively managing metabolic conditions and younger viewers optimizing preventively. The majority-female viewership is consistent with broader patterns in metabolic wellness content. An engagement rate well above the category median reflects a community seeking clinical-grade guidance rather than casual health content. His partnership with Ketone-IQ maps cleanly onto his low-insulin dietary framework, and his expanding focus on peptide therapies, growth hormone secretagogues, and GLP-1 skepticism positions him to capture audience interest as those topics migrate from longevity subcultures into mainstream medical conversation.
Benbikman reaches an audience concentrated in United States primarily through YouTube, and is best activated via long-form YouTube integrations. Their sponsorship history skews toward Nutrition / Metabolic Health, a clear signal of fit for brands in those categories. Demonstrated partners include Ketone-IQ and HLTH Code. Engagement on YouTube runs around 5.1%, which points to an audience better suited to category-relevant, mid-funnel campaigns than to pure-reach buys. Their YouTube-first format lends itself to integrations that sit inside the creator's usual content rather than running as standalone ads. Because the audience follows health content rather than arriving through untargeted reach, sponsorships that match the channel's subject matter tend to convert more efficiently than broad placements. A consistent, on-topic posting focus gives sponsors a predictable, brand-safe environment, lowering placement risk compared with broad, general-interest channels. Campaigns here are best measured on qualified engagement and consideration within the niche rather than on raw impression volume. For United States-focused brands in Nutrition / Metabolic Health and related categories, Benbikman offers a defined, creative-fit audience rather than broad, low-intent impressions.
Benchmark estimates for a creator at Benbikman's tier (Mid, 229K combined followers, United States). Pulled from CreatorDB's category benchmarks.
The CreatorDB Agency runs end-to-end influencer campaigns globally — shortlisting, outreach, contracting, and performance reporting. Talk to our team about building a campaign around creators in this niche.
Dr. Ben Bikman is a credentialed research scientist with a PhD in bioenergetics. He is a professor of Cell Biology and Physiology at Brigham Young University (BYU), where his lab focuses on insulin resistance and its role in chronic disease. His YouTube channel extends that academic research to a general audience rather than being built on wellness influencer culture.
Dr. Ben Bikman wrote Why We Get Sick, which argues that insulin resistance is the common thread behind many modern chronic diseases, including type 2 diabetes, obesity, and heart disease. The book is widely cited in the low-carb and metabolic health community as a foundational science-backed text.
Dr. Bikman's position is that the most critical thing a newly diagnosed type 2 diabetic should hear is that the condition can be reversed — not just managed — through dietary and lifestyle changes that lower insulin levels. He argues most patients are immediately directed toward medication without being told that metabolic reversal is possible.
Dr. Bikman uses the phrase barcoded carbs to describe ultra-processed, packaged carbohydrate products — essentially any refined carb that comes with a label and a barcode. His argument is that these foods spike insulin rapidly and repeatedly, making them a primary driver of insulin resistance and metabolic dysfunction over time.
Dr. Bikman has covered GLP-1 drugs like Ozempic and Wegovy on his channel, drawing attention to the high rate at which people stop taking them due to side effects, cost, or weight regain after quitting. His broader framing positions sustainable dietary change as a more durable path to metabolic health than ongoing pharmaceutical dependency.
CJC-1295 and Tesamorelin are growth hormone-releasing peptides that Dr. Bikman discusses in the context of fat loss and muscle preservation. His content on #peptides and #growthhormone explores how these compounds interact with metabolic and hormonal pathways, reflecting his broader research interest in how hormones regulate body composition.
Dr. Bikman uses the fat burner vs sugar burner framework to describe whether your body preferentially oxidizes fat or glucose for fuel, which is directly tied to your insulin sensitivity. His argument is that chronically elevated insulin — driven by high-carb diets — locks the body into sugar-burning mode, making fat loss physiologically difficult regardless of calorie intake.
Dr. Bikman's research-backed view is that chronically elevated insulin accelerates the cellular and inflammatory processes associated with aging and chronic disease. He regularly states that the duration of time insulin remains low — achieved primarily through diet — is one of the most powerful levers for extending healthspan and reducing disease risk.
Ketone-IQ is an exogenous ketone supplement that Dr. Bikman has promoted as a sponsor on his YouTube channel. The partnership aligns tightly with his core science: ketones are produced when insulin is suppressed and the body shifts into fat-burning mode, making the product a natural fit for his metabolic health messaging.
Dr. Ben Bikman is a professor at Brigham Young University (BYU) in Utah, where he teaches cell biology and physiology and leads research on insulin resistance and metabolic disease. His academic position is a central part of his identity on YouTube, distinguishing his content as peer-informed science education rather than general wellness advice.
Stats (followers, engagement, audience demographics, growth) are pulled live from the CreatorDB API covering YouTube, Instagram and TikTok. Bio and FAQ content is AI-assisted; news items are sourced from cited public press at generation time. Read the full methodology →
If you'd like to update, correct, or remove this profile, get in touch and we'll handle it within 5 business days. We don't publish private data — every stat shown comes from your public platform profiles.
@benbikman · YouTube
+0 new followers
Preparing fresh data…
This usually takes 15–25 seconds.